Products

Imagio Breast Imaging System
Seno Medical Instruments Inc.
Oncology AI
The Imagio® Breast Imaging System is a non-invasive diagnostic tool that looks and feels like a traditional ultrasound. It can be completed quickly after a mammogram to diagnose or rule out breast cancer in abnormal tissue—providing faster answers to patients and diagnostic confidence to clinicians.

See all 1 product →

About Seno Medical Instruments

Seno Medical Instruments is a San Antonio, Texas-based medical imaging company focused on commercializing opto-acoustic imaging, a new modality in cancer diagnosis. Their flagship product, the Imagio® Breast Imaging System, fuses opto-acoustic technology with ultrasound (OA/US) to generate both functional and anatomical images of the breast. The system aims to provide a unique blood map around suspicious breast masses, leveraging the appearance or absence of angiogenesis (growth of blood vessels) and deoxygenation, which are hallmark indicators of cancer.

For physicians, the Imagio® system offers a diagnostic pathway designed to enhance diagnostic confidence and potentially reduce unnecessary biopsies, without exposing patients to ionizing radiation or contrast agents. The system is enhanced by SenoGram®, a native AI clinical decision support tool that provides clinicians with objective scoring to determine the likelihood of malignancy. This technology is intended to provide more precise and earlier diagnosis of smaller tumors and differentiate between benign and malignant growths. The company has received premarket approval (PMA) from the U.S.

Focus Areas

Opto-acoustic imaging breast cancer diagnosis functional imaging angiogenesis deoxygenation AI-based decision support melanoma thyroid cancer prostate cancer colon cancer

Business Intelligence

TechnologyOpto-acoustic imaging (photoacoustic imaging or PAI) fused with ultrasound (OA/US), laser and acoustics integration, functional imaging, AI-based decision support (SenoGram®)

What Physicians Need to Know

Specialization: Opto-acoustic Imaging
Seno Medical Instruments specializes in opto-acoustic (also known as photoacoustic) imaging, which combines laser light and ultrasound to provide both functional and anatomical information about tissue. This technology allows for real-time visualization of blood and oxygen concentration, which are key indicators in differentiating between malignant and benign tissues.
Primary Focus: Breast Cancer Diagnosis
Their flagship product, the Imagio® Breast Imaging System, is designed to improve breast cancer diagnosis by fusing opto-acoustics with gray-scale ultrasound. This system helps clinicians differentiate malignant and benign breast lesions, potentially reducing the need for unnecessary biopsies.
Functional Imaging Capabilities
Seno Medical's technology provides functional imaging by detecting angiogenesis (the growth of new blood vessels) and deoxygenation, two hallmark indicators of cancer. This offers a new view of cancer by showing relative differences between oxygenated and deoxygenated blood.
AI-based Decision Support
The Imagio® system includes SenoGram®, an AI-based decision support tool that assists radiologists in objectively assigning the probability of malignancy. This tool has been shown to improve accuracy in distinguishing benign from malignant masses.
Potential Future Applications
While currently focused on breast cancer, Seno Medical's platform technology has potential follow-on applications for other cancers, including thyroid, head and neck, prostate, cervical, ovarian, and bladder cancers, as well as therapeutic monitoring of drugs.
Physician Tip

For physicians, Seno Medical's Imagio® Breast Imaging System offers a non-invasive diagnostic tool that provides real-time functional and anatomical information, aiding in the differentiation of benign and malignant breast lesions. This can lead to increased diagnostic confidence and potentially reduce the number of false-positive biopsies, improving patient experience and practice efficiency. The AI-based SenoGram® further enhances diagnostic accuracy by providing objective malignancy probability. The system has received FDA PMA approval for breast cancer diagnosis in the U.S. and a Category III CPT code for reimbursement.

The Imagio® Breast Imaging System integrates opto-acoustic technology with conventional diagnostic ultrasound, including color and pulsed wave Doppler for fluid flow analysis. The system also incorporates SenoGram®, its native AI clinical decision support tool, directly into the diagnostic workflow. While specific integrations with other EMR or PACS systems are not detailed, the system is designed to simplify the diagnostic pathway and provide real-time results. Seno Medical also offers Seno University, an on-demand virtual learning platform, to help users gain confidence with the system.

Products by Seno Medical Instruments

1 product in the directory

Imagio Breast Imaging System
Seno Medical Instruments Inc.
Oncology AI
The Imagio® Breast Imaging System is a non-invasive diagnostic tool that looks and feels like a traditional ultrasound. It can be completed quickly after a mammogram to diagnose or rule out breast cancer in abnormal tissue—providing faster answers to patients and diagnostic confidence to clinicians.

Videos

News, demos, and interviews about Seno Medical Instruments.

Loading videos...

Videos load interactively. If none appear, search YouTube for Seno Medical Instruments →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Seno Medical Instruments' core product is the Imagio® Breast Imaging System, which combines opto-acoustic (OA) technology with gray-scale ultrasound. This system provides both functional and anatomical information about breast tissue by mapping blood and oxygen concentration, helping clinicians differentiate between malignant and benign masses in real-time and potentially reducing the need for unnecessary biopsies.
Opto-acoustic imaging, also known as photoacoustic imaging, uses laser light to cause microscopic expansion of cells, generating ultrasound signals. The Imagio® system specifically uses two wavelengths of laser light to show relative differences between oxygenated and deoxygenated blood. Malignant tumors often exhibit increased angiogenesis (new blood vessel growth) and higher rates of deoxygenation, which are key indicators that the Imagio® system can visualize to help identify cancerous tissue.
Seno Medical's Imagio® system includes an AI-based clinical decision support tool called SenoGram®. This tool assists radiologists in objectively assigning the probability of malignancy by interpreting ultrasound and opto-acoustic feature scores, along with clinical features, to provide greater accuracy in distinguishing benign from malignant masses.
While Seno Medical's first clinical product targets breast cancer diagnosis, the company's opto-acoustic platform technology has potential for future applications in other forms of cancer. These could include thyroid, head and neck, prostate, cervical, ovarian, bladder, melanoma, and colon cancers.
The Imagio® Breast Imaging System received Premarket Approval (PMA) from the U.S. FDA in January 2021, with a supplemental PMA approval for its latest device in June 2022. Seno Medical also obtained European Union (EU) Medical Device Regulation (MDR) CE Mark Certification in January 2026 for its next-generation Imagio® Imaging System. Seno Medical supports device cybersecurity through risk management and active vulnerability monitoring.

Related Companies

Radin Health offers a comprehensive suite of AI-powered, cloud-based solutions designed to enhance operational efficiency across all stages of the radiology workflow. Their platform integrates a Radiology Information System (RIS), Picture Archiving and Communication System (PACS), AI-driven Dictation, and RADIN SELECT for workflow management. These solutions aim to improve efficiency and productivity for administrators, medical […]

Spectrum Dynamics Medical is a pioneering medical device company focused on transforming nuclear medicine from analog to digital technology. They specialize in developing high-definition, solid-state based nuclear imaging technology, including digital SPECT (Single Photon Emission Computed Tomography) and SPECT/CT systems. Their products aim to meet the clinical needs and workflow demands of diagnostic imaging departments […]

Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]

Siemens Healthineers is a leading global medical technology company that pioneers breakthroughs in healthcare. The company focuses on medical technology and diagnostics, offering a wide range of products including imaging systems, laboratory diagnostics, and advanced therapies. Their innovations aim to improve patient outcomes and make healthcare more accessible and sustainable. Siemens Healthineers has a strong […]

Samsung Medison Co. is a global medical equipment company specializing in diagnostic imaging devices, particularly ultrasound systems. Established in 1985, the company has become the largest manufacturer of ultrasound systems in Korea. Samsung Medison integrates advanced technologies, including information technology, video signal processing, semiconductors, and communication, into its medical equipment. This integration enables the development […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.